Biodegradable material for treating orthopedic diseases and application thereof
A biodegradable material, orthopedic disease technology, applied in medical science, drug delivery, prosthesis, etc., can solve problems such as high cost, thrombosis, lack of trauma in osteoarthritis, achieve good biocompatibility, improve joints Function, effect of protecting articular cartilage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Example 1 Preparation of Injection Molded Biodegradable Materials for Treatment of Osteoarthritis
[0034] Accurately weigh glycolide-lactide copolymer (PLGA) and N-methylpyrrolidone (NMP), the weight ratio of the two is 10:90; transfer N-methylpyrrolidone (NMP) to a stainless steel liquid mixing tank , stir with a stirring paddle at low speed (200-400rpm), slowly add PLGA powder to disperse and fully dissolve to obtain a relatively stable solution system; then use a 0.22 μm sterile filter to filter and sterilize the solution system. Filtration is completed and filled to obtain an injection-molded biodegradable material for treating osteoarthritis. Protect from light and store at room temperature.
[0035] The product requires technical testing, including observation, identification, and determination of molecular weight. At the same time, heavy metals, solvent residues, moisture, sterility, bacterial endotoxins, biological properties, physical and mechanical propertie...
Embodiment 2
[0037] Example 2 Preparation of Injection Molded Biodegradable Materials for Treatment of Osteoarthritis
[0038] Except that the weight ratio of glycolide-lactide copolymer (PLGA) and N-methylpyrrolidone (NMP) is 5:95; other preparation processes are the same as in Example 1.
Embodiment 3
[0039] Example 3 Preparation of Injection Molded Biodegradable Materials for Treatment of Osteoarthritis
[0040] Except that the weight ratio of glycolide-lactide copolymer (PLGA) and N-methylpyrrolidone (NMP) is 50:50; other preparation processes are the same as in Example 1.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


